Four Inc. Secures Spot on Washington Technology’s Top 100 Government Contractors List for 11th Consecutive Year 
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results IN8bio Announces Positive Preclinical Data for Gamma-Delta CAR Platform and Launches New CD33 Program at AACR Annual Meeting 2023
INB-300, a gamma-delta T cell chimeric antigen receptor (CAR) platform, demonstrated the ability to target…
Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting
IK-930 is a potent Hippo pathway inhibitor that selectively binds TEAD1 and broadly represses oncogenic…
Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting
IK-930 is a potent Hippo pathway inhibitor that selectively binds TEAD1 and broadly represses oncogenic…
Tempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting
BRISBANE, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage…
Tempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting
BRISBANE, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage…
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
VTP-200 was generally well-tolerated and was administered with no product-related grade 3 unsolicited adverse events…
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
VTP-200 was generally well-tolerated and was administered with no product-related grade 3 unsolicited adverse events…
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
– Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains…
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
– Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains…
Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors
BERKELEY HEIGHTS, N.J., April 17, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors
BERKELEY HEIGHTS, N.J., April 17, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey
Roger Estafanos ITM announces a new General Manager for U.S. ITM U.S. Headquarters ITM Opens…
ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey
Roger Estafanos ITM announces a new General Manager for U.S. ITM U.S. Headquarters ITM Opens…
Praxis Precision Medicines Announces Upcoming Ulixacaltamide Presentations & Events
Ulixacaltamide essential tremor end-of-phase 2 meeting with FDA scheduled for June 2023 BOSTON, April 17,…
Praxis Precision Medicines Announces Upcoming Ulixacaltamide Presentations & Events
Ulixacaltamide essential tremor end-of-phase 2 meeting with FDA scheduled for June 2023 BOSTON, April 17,…
Windtree Therapeutics Announces Issuance of New Dual Mechanism SERCA2a Activator Patent
Compounds that activate SERCA2a may lead to novel therapies for heart failure WARRINGTON, Pa., April…
Windtree Therapeutics Announces Issuance of New Dual Mechanism SERCA2a Activator Patent
Compounds that activate SERCA2a may lead to novel therapies for heart failure WARRINGTON, Pa., April…
binx health Further Expands Commercial Team in Support of Point-of-Care National Rollout
Sales, Customer Support, and Market Access Teams Grow to Meet Rising Demand for Near-Patient Solutions…
binx health Further Expands Commercial Team in Support of Point-of-Care National Rollout
Sales, Customer Support, and Market Access Teams Grow to Meet Rising Demand for Near-Patient Solutions…
PepGen Announces Upcoming Data Presentations at the 2023 American Academy of Neurology Annual Meeting
BOSTON, April 17, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company…